{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:25:50Z","timestamp":1787009150286,"version":"build-2736575974"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"ohns Hopkins Hospital Department of Pathology"},{"DOI":"10.13039\/100016450","name":"Department of Neurology and Neurosurgery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016450","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Johns Hopkins University School of Medicine Physician-Scientist Training Program"},{"name":"Johns Hopkins Alzheimer\u2019s Disease Research Center","award":["P30AG066507"],"award-info":[{"award-number":["P30AG066507"]}]},{"name":"Johns Hopkins Center for the Advancement of HIV Neurotherapeutics","award":["P30MH075673"],"award-info":[{"award-number":["P30MH075673"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Combination antiretroviral therapy (cART) has reduced the incidence of HIV-related mortality, leading to a growing population of older virally suppressed people with HIV (PWH). cART has also decreased the prevalence of HIV-associated dementia; however, many virally suppressed PWH still experience milder forms of cognitive impairment. It remains unclear whether aging virally suppressed PWH demonstrate distinct risks or patterns of neurodegenerative pathology. We examined brain tissue of 13 virally suppressed PWH and 13 matched HIV-negative controls from a community-based cohort and characterized \u03b2-amyloid (A\u03b2), tau, \u03b1-synuclein, and TDP-43 pathology. Both groups had similar demographics, medical comorbidities, and routine histologic brain findings. PWH demonstrated trends toward an increased prevalence of both Alzheimer disease (AD) and non-AD neurodegenerative pathologies, including A\u03b2 pathology, higher stage tau pathology, aging-related tau astrogliopathy, and \u03b1-synuclein pathology. They showed similar trends toward increased severity of A\u03b2 and tau pathology. We also identified a negative correlation between the burden of entorhinal cortical neurofibrillary tangles and end-of-life body mass index in PWH. Thus, PWH may have a greater burden of neurodegenerative pathology, including both AD and non-AD neurodegenerative pathologies; there is a need for the assessment of neurodegenerative pathology in community-based cohort studies to understand mechanisms of HIV-associated neuropathology and cognitive impairment in aging virally suppressed PWH.<\/jats:p>","DOI":"10.1093\/jnen\/nlaf102","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T12:10:39Z","timestamp":1754655039000},"page":"1094-1105","source":"Crossref","is-referenced-by-count":4,"title":["Neuropathologic findings in a community-based autopsy cohort of older, virally suppressed, people with HIV"],"prefix":"10.1093","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3055-2810","authenticated-orcid":false,"given":"Thomas D","family":"Zaikos","sequence":"first","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9678-1777","authenticated-orcid":false,"given":"Haidan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Barrett","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4992-711X","authenticated-orcid":false,"given":"Raha","family":"Dastgheyb","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah H","family":"Rubin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Department of Epidemiology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Troncoso","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]},{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5340-148X","authenticated-orcid":false,"given":"Meaghan","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"2025121810570724700_nlaf102-B1","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","author":"Antiretroviral Therapy Cohort Collaboration","year":"2017","journal-title":"Lancet HIV"},{"key":"2025121810570724700_nlaf102-B2","first-page":"28","author":"Centers for Disease Control and Prevention","year":"2024"},{"key":"2025121810570724700_nlaf102-B3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22053","article-title":"Human immunodeficiency virus-associated neurocognitive disorders: mind the gap","volume":"67","author":"McArthur","year":"2010","journal-title":"Ann Neurol"},{"key":"2025121810570724700_nlaf102-B4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"J Neurovirol"},{"key":"2025121810570724700_nlaf102-B5","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1212\/WNL.42.8.1472","article-title":"Epidemiology of human immunodeficiency virus encephalopathy in the United States","volume":"42","author":"Janssen","year":"1992","journal-title":"Neurology"},{"key":"2025121810570724700_nlaf102-B6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11904-015-0266-8","article-title":"Neuropathology of HAND with suppressive antiretroviral therapy: encephalitis and neurodegeneration reconsidered","volume":"12","author":"Gelman","year":"2015","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2025121810570724700_nlaf102-B7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.410360422","article-title":"Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome","volume":"36","author":"Wiley","year":"1994","journal-title":"Ann Neurol"},{"key":"2025121810570724700_nlaf102-B8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1017\/S1355617700000308","article-title":"Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center","volume":"1","author":"White","year":"1995","journal-title":"J Int Neuropsychol Soc"},{"key":"2025121810570724700_nlaf102-B9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1017\/S1355617700000230","article-title":"The HNRC 500\u2014neuropsychology of HIV infection at different disease stages. HIV neurobehavioral research center","volume":"1","author":"Heaton","year":"1995","journal-title":"J Int Neuropsychol Soc"},{"key":"2025121810570724700_nlaf102-B10","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"2025121810570724700_nlaf102-B11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40478-022-01375-y","article-title":"Frontal lobe microglia, neurodegenerative protein accumulation, and cognitive function in people with HIV","volume":"10","author":"Murray","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"2025121810570724700_nlaf102-B12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jnen\/nlac040","article-title":"Neuropathologic findings in elderly HIV-positive individuals","volume":"81","author":"Magaki","year":"2022","journal-title":"J Neuropathol Exp Neurol"},{"key":"2025121810570724700_nlaf102-B13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12879-017-2246-7","article-title":"Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era","volume":"17","author":"Solomon","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2025121810570724700_nlaf102-B14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/13550280903131915","article-title":"Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy","volume":"15","author":"Everall","year":"2009","journal-title":"J Neurovirol"},{"key":"2025121810570724700_nlaf102-B15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13550280802578075","article-title":"Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection","volume":"15","author":"Khanlou","year":"2009","journal-title":"J Neurovirol"},{"key":"2025121810570724700_nlaf102-B16","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s12035-019-01795-3","article-title":"White matter abnormalities linked to interferon, stress response, and energy metabolism gene expression changes in older HIV-Positive patients on antiretroviral therapy","volume":"57","author":"Solomon","year":"2020","journal-title":"Mol Neurobiol"},{"key":"2025121810570724700_nlaf102-B17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11481-009-9152-8","article-title":"Increased accumulation of intraneuronal amyloid beta in HIV-infected patients","volume":"4","author":"Achim","year":"2009","journal-title":"J Neuroimmune Pharmacol"},{"key":"2025121810570724700_nlaf102-B18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00401-006-0037-0","article-title":"Accelerated tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy","volume":"111","author":"Anthony","year":"2006","journal-title":"Acta Neuropathol"},{"key":"2025121810570724700_nlaf102-B19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s13365-023-01181-9","article-title":"Predictors of hippocampal tauopathy in people with and at risk for human immunodeficiency virus infection","volume":"29","author":"Nader","year":"2023","journal-title":"J Neurovirol"},{"key":"2025121810570724700_nlaf102-B20","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/QAD.0000000000003556","article-title":"Neuronal accumulation of hyperphosphorylated tau protein predicts stable memory impairment in people living with HIV","volume":"37","author":"Gonzalez","year":"2023","journal-title":"AIDS"},{"key":"2025121810570724700_nlaf102-B21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jnnp.65.1.29","article-title":"Prevalence of Alzheimer plaques in AIDS","volume":"65","author":"Esiri","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025121810570724700_nlaf102-B22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","article-title":"Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients","volume":"19","author":"Green","year":"2005","journal-title":"AIDS"},{"key":"2025121810570724700_nlaf102-B23","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1097\/QAD.0b013e32835a117c","article-title":"Cerebral beta-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE epsilon4 carriers","volume":"26","author":"Soontornniyomkij","year":"2012","journal-title":"AIDS"},{"key":"2025121810570724700_nlaf102-B24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s13365-018-0663-z","article-title":"Alzheimer\u2019s disease neuropathology may not predict functional impairment in HIV: a report of two individuals","volume":"24","author":"Morgello","year":"2018","journal-title":"J Neurovirol"},{"key":"2025121810570724700_nlaf102-B25","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"2025121810570724700_nlaf102-B26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary Age-Related Tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol"},{"key":"2025121810570724700_nlaf102-B27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","article-title":"Aging-Related Tau Astrogliopathy (ARTAG): harmonized evaluation strategy","volume":"131","author":"Kovacs","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2025121810570724700_nlaf102-B28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"2025121810570724700_nlaf102-B29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"2025121810570724700_nlaf102-B30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"key":"2025121810570724700_nlaf102-B31","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with lewy bodies: third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"2025121810570724700_nlaf102-B32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-022-02524-2","article-title":"LATE-NC staging in routine neuropathologic diagnosis: an update","volume":"145","author":"Nelson","year":"2023","journal-title":"Acta Neuropathol"},{"key":"2025121810570724700_nlaf102-B33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40478-019-0743-1","article-title":"Resistance and resilience to Alzheimer\u2019s disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort","volume":"7","author":"Latimer","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"2025121810570724700_nlaf102-B34","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.3892\/mmr.2015.4251","article-title":"Amplification refractory mutation system polymerase chain reaction versus optimized polymerase chain reaction restriction-fragment length polymorphism for apolipoprotein E genotyping of majorly depressed patients","volume":"12","author":"You","year":"2015","journal-title":"Mol Med Rep"},{"key":"2025121810570724700_nlaf102-B35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11904-018-0383-2","article-title":"Sex differences in HIV infection","volume":"15","author":"Scully","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2025121810570724700_nlaf102-B36","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00401-018-1908-x","article-title":"Sex and age interact to determine clinicopathologic differences in Alzheimer\u2019s disease","volume":"136","author":"Liesinger","year":"2018","journal-title":"Acta Neuropathol"},{"key":"2025121810570724700_nlaf102-B37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/alz.13422","article-title":"Different cohort, disparate results: selection bias is a key factor in autopsy cohorts","volume":"20","author":"Gauthreaux","year":"2024","journal-title":"Alzheimers Dement"},{"key":"2025121810570724700_nlaf102-B38","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3233\/JAD-2009-1227","article-title":"The neuropathology of older persons with and without dementia from community versus clinic cohorts","volume":"18","author":"Schneider","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"2025121810570724700_nlaf102-B39","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1532-5415.1996.tb01836.x","article-title":"Impact of sample selection on APOE epsilon 4 allele frequency: a comparison of two Alzheimer\u2019s disease samples","volume":"44","author":"Tsuang","year":"1996","journal-title":"J Am Geriatr Soc"},{"key":"2025121810570724700_nlaf102-B40","first-page":"21","year":"2024"},{"key":"2025121810570724700_nlaf102-B41","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/infdis\/jiv277","article-title":"HIV-1 infection accelerates age according to the epigenetic clock","volume":"212","author":"Horvath","year":"2015","journal-title":"J Infect Dis"},{"key":"2025121810570724700_nlaf102-B42","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"2025121810570724700_nlaf102-B43","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.neuron.2022.12.029","article-title":"Virus exposure and neurodegenerative disease risk across national biobanks","volume":"111","author":"Levine","year":"2023","journal-title":"Neuron"},{"key":"2025121810570724700_nlaf102-B44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnagi.2018.00324","article-title":"Corroboration of a major role for herpes simplex virus type 1 in Alzheimer\u2019s disease","volume":"10","author":"Itzhaki","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"2025121810570724700_nlaf102-B45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0197-4580(96)00069-3","article-title":"On the relationship between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis","volume":"17","author":"Bancher","year":"1996","journal-title":"Neurobiol Aging"},{"key":"2025121810570724700_nlaf102-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-220800","article-title":"COVID-19 as a risk factor for Alzheimer\u2019s disease","volume":"91","author":"Golzari-Sorkheh","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"2025121810570724700_nlaf102-B47","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3390\/genes15060745","article-title":"Human endogenous retroviruses in neurodegenerative diseases","volume":"15","author":"Adler","year":"2024","journal-title":"Genes (Basel)"},{"key":"2025121810570724700_nlaf102-B48","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"key":"2025121810570724700_nlaf102-B49","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/QAD.0000000000002893","article-title":"HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition","volume":"35","author":"Morgello","year":"2021","journal-title":"AIDS"},{"key":"2025121810570724700_nlaf102-B50","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025121810570724700_nlaf102-B51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JAD-130698","article-title":"Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort","volume":"38","author":"Tolppanen","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"2025121810570724700_nlaf102-B52","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3233\/JAD-161205","article-title":"Modeling the relationships among late-life body mass index, cerebrovascular disease, and Alzheimer\u2019s disease neuropathology in an autopsy sample of 1,421 subjects from the National Alzheimer\u2019s coordinating center data set","volume":"57","author":"Alosco","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"2025121810570724700_nlaf102-B53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/WNR.0b013e3283412868","article-title":"Hippocampal volume is related to body mass index in Alzheimer\u2019s disease","volume":"22","author":"Ho","year":"2011","journal-title":"Neuroreport"},{"key":"2025121810570724700_nlaf102-B54","author":"Center for HIV Surveillance, Epidemiology and Evaluation"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/84\/12\/1094\/64162788\/nlaf102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/84\/12\/1094\/64162788\/nlaf102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:57:36Z","timestamp":1766073456000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/84\/12\/1094\/8244216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,8,29]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlaf102","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,8,29]]}}}